As regulatory and payer scrutiny continues to rise, it’s more important than ever to protect the market potential of your device or diagnostic from being diminished. With the right data collection strategy, you can refine define a value story early in development and prevent post-approval study costs from eclipsing product revenue.
At this year’s AdvaMed, gain insights on the most successful reimbursement strategies from panels featuring leading medical device experts. Join ICON’s Susan Rockwell, Executive Director of Medical Device Strategy and Vicki Anastasi, Senior VP of Medical Devices Vice President and Global Head Medical Device & Diagnostics Research as they discuss:
- Optimal global IVD clinical trial operations and OUS market reimbursement strategies
- Reimbursement negotiations and other market entry strategies in the US multi-payer healthcare system
You can also book a private consultation with James Eaton, Director of Health Economics at ICON, to review your reimbursement strategy.
With more than 600 successful device trials in over 3840 countries, ICON has developed effective market access strategies across a broad spectrum of therapeutic areas, including cardiovascular, orthopedics, IVDs and companion diagnostics.